東華能源(002221.SZ):向相關合作銀行申請共計不超26.6億元的綜合授信
格隆匯3月16日丨東華能源(002221.SZ)公佈,公司第五屆董事會第十二次會議召開,審議通過《關於公司及子公司向銀行申請綜合授信的議案》;
因公司經營業務需要,董事會審議同意,公司及公司的控股子公司太倉東華能源燃氣有限公司(“太倉東華”)、東華能源(寧波)新材料有限公司(“寧波新材料”)、南京東華能源燃氣有限公司(“南京東華”)、寧波百地年液化石油氣有限公司(“寧波百地年”)、東華能源(新加坡)國際貿易有限公司(“新加坡東華”)向相關合作銀行申請共計不超過26.60億元人民幣的綜合授信(原授信額度為21.30億元人民幣),上述額度在獲得有關銀行審批後生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.